三七互娛(002555.SZ)逆勢漲超5% 逼近前高
格隆匯11月11日丨三七互娛(002555.SZ)今日逆勢大漲,現報19.39元,漲5.38%,暫成交4.46億元,最新總市值410億元,逼近9月底創出的階段高位。

公司曾於10月30日發佈三季報及全年業績預告顯示,公司單季營收創新高,且預計2019年淨利為20.5億元-21.5億元,同比增長103%-113%,業績增長得益於手遊研發及發行業務持續增長。
公司三季報還顯示高毅資本出現在公司前十大股東中,持股比例為2.3%。
另外,三七互娛還入股了近日高票房的《少年的你》的聯合出品方中匯影視,截至今日,《少年的你》上映18天票房已逼近14億,超市場預期。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.